Aqua Bio Technology ASA: Key information notice relating to reverse share split and change of ISIN

Reference is made to the resolution by the annual general meeting of Aqua Bio Technology ASA (the "Company") on 16 February 2026, regarding, inter alia, a share consolidation (reverse share split) of the Company's shares in the ratio of 50:1. Key information related to the reverse share split is set out below: · Reverse split ratio: 50:1, i.e. fifty (50) old shares give one (1) new share · Date on which the corporate action was made public: 26 January 2026 · Last day including right: 26 February 2026 · Ex-date: 27 February 2026 · Record Date: 2 March 2026 · Date of approval: 16 February 2026 Following completion of the share consolidation, the par value of the Company's shares will be increased from NOK 0.10 to NOK 5.00. Shareholders who do not own a number of shares which can be divided by 50 shall, in connection with the reverse share split, have their shareholding rounded downwards, so that the shareholder receives a whole number of shares. Fractional shares will not be issued, and the shareholder will not receive any compensation for the rounding. The fractional shares will be added together to whole shares and will be sold at Euronext Expand. The net proceeds from such sale shall be donated to a charitable purpose as determined by the Board of Directors. In connection with the reverse share split, the Company's shares will be transferred to a new ISIN. Key information for the change of ISIN is set out below: · Issuer: Aqua Bio Technology ASA · Previous ISIN: NO 001 0307135 · New ISIN: NO 001 3735894 · Date of ISIN change: 27 February 2026

Contacts Kristian Flaten CEO & CFO Aqua Bio Technology ASA

Phone: +47 9509 2322 Email: kf@aquabiotech.no

About Us Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in skincare and nonfood. The group has distribution towards B2C and B2B, and offers freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 17. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-02-25 07:57 CET.